Ledger.Open graph →

SEC Form D · Amendment · filed August 26, 2025

Orion Biotechnology Canada Ltd

Offering

$15.0M

Sold

$6.8M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

OTTAWA, ONTARIO, Z4

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Bradford Smith · Ottawa, Ontario, Z4Director Jean Forcione · Ottawa, Ontario, Z4Director Praveen Tyle · Ottawa, Ontario, Z4Exec · Director Anatolii Klepatsky · Ottawa, Ontario, Z4Exec · Director Mark Groper · Ottawa, Ontario, Z4Director John Jussup · Ottawa, Ontario, Z4Exec Lonnel Coats · Ottawa, Ontario, CanadaDirector Katie Hewitt · Ottawa, Ontario, CanadaDirector John Jussup · Ottawa, Ontario, Z4Exec Anatolii Klepatsky · Ottawa, Ontario, Z4Exec · Director Mark Groper · Ottawa, Ontario, Z4Director Praveen Tyle · Ottawa, Ontario, Z4Exec · Director Jean Forcione · Ottawa, Ontario, Z4Director Bradford Smith · Ottawa, Ontario, Z4Director Wesley Barton · NEW YORK, NYDirector Keith Hamlin · NEW YORK, NYExec Michael Kim · NEW YORK, NYDirector Third Prime Managers Iv, LLC · NEW YORK, NYExec · Director Jacob Pickle · Austin, TXExec · Director Anthony Alfonzetti · Austin, TXDirector Lonnel Coats · Ottawa, Ontario, CanadaDirector Katie Hewitt · Ottawa, Ontario, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗